Status:
COMPLETED
Reduce Sedentary Behavior at Work
Lead Sponsor:
Medical College of Wisconsin
Conditions:
Sedentary Lifestyle
Obesity
Eligibility:
All Genders
18-50 years
Brief Summary
Prior research suggests that sedentary behavior is detrimental to health, independent of exercise activity. Sedentary behavior is defined as behaviors that involve low levels of energy expenditure ≤1....
Detailed Description
The hypothesis is that obese subjects with sedentary jobs at the Medical College of Wisconsin, when assigned use of a standing desk to encourage movement, will reduce their daily sedentary time and de...
Eligibility Criteria
Inclusion
- Sedentary office workers the Medical College of Wisconsin who spend greater than 75% of their (8 hours or longer) work-day sitting at a desk. This includes at least 1 period of 2 hours or longer of uninterrupted sitting time per work day.
- Body mass index of 26.0-44.9
- Willing and able to sign Informed consent
- Permission from the subject's supervisor to participate in the intervention
Exclusion
- Known history of atherosclerotic cardiovascular disease, including myocardial infarction, stroke, coronary stent, coronary artery bypass grafting, angina and peripheral vascular disease
- Diabetics on insulin or other diabetic medications (pre-diabetes would be acceptable, defined as a HbgA1c of 5.7 to 6.4%, and not on medications)
- Elevated blood pressure (SBP≥150 mm Hg or DBP ≥90 mm Hg) or on medication for hypertension; or SBP \< 100 mm Hg.
- On cholesterol-lowering medication or LDL-C cholesterol ≥190 mg/dL
- Pregnancy, lactating or planning to get pregnant within the next 6 months
- Current tobacco use within previous 12 months. Tobacco use included cigarettes, cigars, and all forms of smokeless tobacco.
- Current excessive alcohol use (defined as more than 14 drinks/week for women, more than 28 drinks/week for men)
- Current illicit drug use, defined as overuse of prescription medications, or of any illegal mind altering substances.
- Known thyroid disease
- Taking diet pills, or supplements other than those contained in a multi-vitamin
- History of musculoskeletal surgery/injury that would interfere with prolonged periods of standing
- History of use of PDE-5 inhibitors for any reason within the last 5 days of screening visit, and the inability to hold use of PDE-5 inhibitors for 5 days prior to each of the FMD evaluations.
Key Trial Info
Start Date :
June 13 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT03816150
Start Date
June 13 2016
End Date
November 30 2020
Last Update
September 30 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.